Abstract. Background: STEMI with onset ≤12 hours, necessary to take Primary Percutaneous Coronary Intervention (pPCI), but if there is no facility, another therapy is fibrinolytic, to improve blood flow in the coronary artery and myocardial function, thus reducing infarction expansion. This is a retrospective study in STEMI patient's onset ≤12 hours, had performed successful fibrinolytic with Streptokinase (SK) and Alteplase (tPA) from January 2015 to August 2017. TIMI flow was assessed by coronary angiography. There were 54 patients who had performed successful fibrinolytic therapy with SK and tPA; each group had 27 patients. In the SK group, there were nine patients (33.3%) with TIMI flow 2 and 18 patients (66.7%) with TIMI flow 3. While in the tPA group there were 11 patients (40.7%) with TIMI flow 2, 16 patients (59.3%) with TIMI flow 3, (p=0.573). There is no difference in TIMI flow between SK and tPA on STEMI patients after success fibrinolytic therapy. TIMI 2, 16 pasien (59,3%) dengan aliran TIMI 3, (p = 0,573). Tidak ada perbedaan dalam aliran TIMI antara SK dan tPA pada pasien STEMI setelah terapi fibrinolitik sukses.
Introduction
Fibrinolytic therapy is used to improve blood flow in the coronary due to occlusion caused by thrombus, thereby reducing infarction expansion, improving myocardial function in the patient with STEMI [1] . De Lemoss et al. (2001) , compared the angiographic reperfusion assessment with the ST segment resolution assessment on the administration of SK with tPA. Both fibrinolytic agents have more ST-segment resolution correlations and a higher average IRA patency with TIMI flow 3. However, tPA has a better TIMI flow compared to SK [2] . The aim of this study was to assess and compare TIMI flow between fibrinolytic agents SK and tPA after successful fibrinolytic.
Methodology
We examined data from medical records of patients who treated at Haji Adam Malik General
Hospital from January 2015 to July 2017. Samples were patients who had been diagnosed with STEMI onset ≤ 12 hours, which had successfully performed fibrinolytic therapy with SK or tPA, and given the same dual antiplatelet (Aspilet 160 mg and Clopidogrel 300 mg) before performed fibrinolytic therapy, then followed by five days of Enoxaparin. We examined early ECG recording and 90 minutes after fibrinolytic, laboratory examination, coronary angiography record.
Succeed fibrinolytic is a decreased ST segment ≥ 50%, at least two paired leads, compare early ECG and 90-minute ECG after fibrinolytic. Then the whole sample is divided into two groups, first group with SK, and the second group with tPA. Assessment of TIMI flow was performed by two interventions cardiologist through a coronary angiography recording.
The data are presented descriptively with frequency distribution and percentage for categorical data. While numerical data is presented with mean and Standard Deviation (SD) values for normally distributed data, while abnormally distributed data with the median. The normality test of numerical variables in all subjects will use Kolmogorov Smirnov (n> 50). Both categorical variables will be tested the correlation, whether there is a significant correlation. Analysis of statistical data using SPSS software version 20, p-value <0.05 is statistically significant.
Results
Total samples were 54 patients, and each group had 27 samples. The mean age was 53 years for the SK group and 56 years in the tPA group. Males were the largest sample, 48 patients (88.9%), which 25 patients (92.6%) in the SK group and 23 patients (85.2%) in the tPA group. Total risk factor for CHD was highest in age and smoking was 43 patients.
This study divided STEMI into two groups, anterior and Inferior STEMI. In the SK group, inferior STEMI compared to the anterior STEMI, 15 patients (55.6%) and 12 patients (44.4%). In the tPA group, Anterior STEMI was more that 19 patients (70.4%), compared with Inferior STEMI 8 patients (29.6%). The onset of chest pain divided into four groups. The onset of chest pain was greater in the > 3-6 hour's group, 25 patients (46.3%), of which 11 patients (40.7%) in the SK group and 14 patients (51.9%) in the tPA group. The second onset of chest pain group was 0-3 hours, 21 patients (38.9%), 12 patients in the SK group (44.4%) while in the tPA group of 9 patients (33.3%) ( Table 1 ).
In the laboratory characteristics were found statistically significant differences between the SK and tPA groups, there are MPV and cardiac enzymes (Troponin and CKMB). On the MPV assessment in the SK group, an average value was 9.56 fL, whereas in the tPA group was 9.99 fL (p value= 0.044). In the cardiac enzyme group with p-value = 0.000, which Troponin values were divided into two groups (+) and (-). 24 patients (44.4%) with positive troponin, which five patients (5%) in the SK group and 19 patients (70.4%) in the tPA group. The CKMB cardiac enzyme examination in this study was also significant with p-value = 0.003, whereas the median of the SK group was 35 units / L, while in the tPA group was 62 units / L ( Table 1) .
Twenty patients (37%) with TIMI flow 2, while 34 patients (63%) with TIMI flow 3. In the SK group, TIMI flow two there were nine patients (33.3%), and TIMI flow 3 is 18 patients (66.7%), while in the tPA group, 11 patients (40.7%) with TIMI flow 2 and 16 patients (59.3%) with TIMI flow 3. The TIMI flow ratio between SK and tPA was not was statistically significant with pvalue= 0,573 (table 2). The TIMI flow assessment was observed with two interventionists. The value of Kappa (κ) inter-observer variability is 0.623 (p-value = 0.000). 
Discussion
From the baseline characteristics found that men were most often found in STEMI, with a total of 48 people (88.9%). Previous research says that the number of STEMI events is more common in man as much as 3-4 times compared with the woman [3] , [4] . The average age was 54 years old, with the lowest age range 46 years old, and the highest age of 62 years old. An increasing in age risk factor, the incidence of cardiovascular disease also increases [4] .
This study was divided into two major groups, anterior and inferior STEMI. Where overall anterior STEMI was greater than inferior. The results of this study are consistent with those of Kennedy et al. (1979) , anterior STEMI is more common when compared with inferior STEMI [5] . The results showed that STEMI patients came with an average of 3 to 6 hours of onset, with a total of 25 patients (46.3%), of which 11 were fibrinolytic with SK and 14 with tPA, with median 4 hours, the onset range of 0.5 hours to 11.5 hours. Then followed by an onset of fewer than 3 hours, amounting to 21 patients (38.9%), with 12 patients performed fibrinolytic with SK and nine other patients with TPA. Compared with previous studies, where the high-fibrinolytic efficacy of onset<6 hours, and fibrinolytic action with onset <3 hours, the results given almost the same as the pPCI [4] .
The results of laboratory tests are significant, i.e. MPV, Troponin and CKMB. The average value of MPV from 2 large groups of fibrinolytic equal to 9.77 fL (p-value = 0.044). From this results it can be concluded that the initial value of MPV is low, the fibrinolytic success rate is higher.
MPV describes platelet function, the study of Bath et al. (1996) , assessed that high MPV was more aggressive in responding to platelet aggregation, resulting in lower MPV values, decreased platelet adhesion, resulting in increased fibrinolytic success [6] , [7] .
Another assessment of laboratory tests that was statistically significant was troponin levels. In in the TIMI-14 and HIT-4 studies. From these two studies mentioned that TIMI flow 2 and three more in the group TPA, whereas in this study TIMI flow three more on giving SK. The difference of this study with previous, possibly due to anticoagulant before coronary angiography action, thus affecting TIMI flow at the time of coronary angiography. The p-value obtained is 0.573, meaning that there is no difference of TIMI flow between giving of SK and TPA [2] . TIMI flow assessment is subjective, to assess the magnitude of the difference between the two observers the Kappa test was used to see the difference between the observed agreement. From this research got a value of Kappa (K) 0,623, it means a good inter-observer agreement [8] .
Conclusion
From this study, we can conclude that there is no difference of TIMI flow between SK and TPA on STEMI patients after successful fibrinolytic therapy.
